Molecule intelOpportunity: Lower0Crowded market

Pseudoephedrine

189 brands · 107 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
24
Market saturation
100
Price room
100
Regulatory risk
40
189
brands
107
companies
Rs 190
median price
26
price points
27.07x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 4%

Price room

Across observed sources and strengths
CheapestRs 20.73
MedianRs 190
Most expensiveRs 561.11
Spread27.07×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 27.07x across 26 trusted points (Rs 20.73-561.11). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Pseudoephedrine — each links to its own medicine page.

Regulatory alerts

latest 2024-05-07
Drug Safety Alert: Risk of Posterior Reversible Encephalopathy Syndrome (PRES) and Reversi

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

107 canonical companies and 189 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 27.07x across 26 trusted points (Rs 20.73-561.11). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2024-05-07.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.